Guidelines


Relevant guidelines can be found using the following links:


2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC:

2020 Atrial Fibrillation (Management of) Guidelines: ESC Clinical Practice Guidelines

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

For Prescribing Information please click here.

warningThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for how to report adverse events. Reports can also be sent directly to Bayer via this link. Both side effects or quality complaints can be reported to Bayer by email to adr-ireland@bayerhealthcare.com.

The information on this site is intended
for healthcare professionals based in Republic of Ireland only.

Are you a healthcare professional based in Republic of Ireland?

Sorry, the information on this website is intended for healthcare professionals based in Republic of Ireland only.